ANTX
AN2 Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$170.72M
P/E Ratio
—
EPS
$-1.10
Beta
-0.95
52W High
$6.91
52W Low
$1.00
50-Day MA
$4.16
200-Day MA
$2.21
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About AN2 Therapeutics Inc
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -44.60% |
| Return on Assets | -27.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.27 |
| Price-to-Book | 2.09 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $36.02M |
| Float | $17.02M |
| % Insiders | 18.99% |
| % Institutions | 70.48% |
Historical Volatility
HV 10-Day
79.53%
HV 20-Day
68.24%
HV 30-Day
71.11%
HV 60-Day
81.87%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($9.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026